These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Pharmacology of lorcainide. Keefe DL Am J Cardiol; 1984 Aug; 54(4):18B-21B. PubMed ID: 6465043 [TBL] [Abstract][Full Text] [Related]
16. [Effect of magnesium sulphate on the supernormal phase of myocardial excitability (author's transl)]. Critelli G; Maione S; Adinolfi L; Ferro G; Perticone F; Condorelli M Ann Cardiol Angeiol (Paris); 1977 Oct; 26(5):407-11. PubMed ID: 907304 [No Abstract] [Full Text] [Related]
17. [The electrophysiological effects of disopyramide (author's transl)]. Ponsonnaille J; Marcheix JC; Gras H Ann Cardiol Angeiol (Paris); 1977; 26(2):135-9. PubMed ID: 900834 [No Abstract] [Full Text] [Related]
18. Comparison in vitro of the electrophysiological effects of lorcainide and its metabolite norlorcainide. Carmeliet E Eur J Pharmacol; 1987 Jan; 133(1):29-36. PubMed ID: 3556390 [TBL] [Abstract][Full Text] [Related]
19. [Clinical indications of different drugs for refractory arrhythmias (author's transl)]. Leclercq JF; Coumel P Ther Umsch; 1982 Feb; 39(2):128-36. PubMed ID: 7071785 [No Abstract] [Full Text] [Related]
20. Pharmacologic information required for design of programmed electrical stimulation protocols. Roden DM Circulation; 1986 Feb; 73(2 Pt 2):II39-44. PubMed ID: 3080263 [No Abstract] [Full Text] [Related] [Next] [New Search]